{"doi":"10.1002/adhm.202304618","title":"Prostate‐Specific Membrane Antigen Targeted StarPEG Nanocarrier for Imaging and Therapy of Prostate Cancer","abstract":"The tumor uptake of large non-targeted nanocarriers primarily occurs through passive extravasation, known as the enhanced permeability and retention (EPR) effect. Prior studies demonstrated improved tumor uptake and retention of 4-arm 40 kDa star polyethylene glycol (StarPEG) polymers for cancer imaging by adding prostate-specific membrane antigen (PSMA) targeting small molecule ligands. To test PSMA-targeted delivery and therapeutic efficacy, StarPEG nanodrugs with/without three copies of PSMA-targeting ligands, ACUPA, are designed and synthesized. For single-photon emission computed tomography (SPECT) imaging and therapy, each nanocarrier is labeled with 177Lu using DOTA radiometal chelator. The radiolabeled nanodrugs, [177Lu]PEG-(DOTA)1 and [177Lu]PEG-(DOTA)1(ACUPA)3, are evaluated in vitro and in vivo using PSMA+ PC3-Pip and/or PSMA- PC3-Flu cell lines, subcutaneous xenografts and disseminated metastatic models. The nanocarriers are efficiently radiolabeled with 177Lu with molar activities 10.8-15.8 MBq/nmol. Besides excellent in vitro PSMA binding affinity (kD = 51.7 nM), the targeted nanocarrier, [177Lu]PEG-(DOTA)1(ACUPA)3, demonstrated excellent in vivo SPECT imaging contrast with 21.3% ID/g PC3-Pip tumors uptake at 192 h. Single doses of 18.5 MBq [177Lu]PEG-(DOTA)1(ACUPA)3 showed complete resolution of the PC3-Pip xenografts observed up to 138 days. Along with PSMA-targeted excellent imaging contrast, these results demonstrated high treatment efficacy of [177Lu]PEG-(DOTA)1(ACUPA)3 for prostate cancer, with potential for clinical translation.","journal":"Advanced Healthcare Materials","year":2024,"id":436630,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":11,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9453,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2024-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":894779,"name":"Gary W. Ashley","orcid":"0000-0002-5366-9109","position":1,"is_corresponding":false},{"id":1027131,"name":"Kondapa Naidu Bobba","orcid":"0000-0001-6304-2855","position":2,"is_corresponding":false},{"id":1046353,"name":"Anju Wadhwa","orcid":"0009-0006-0826-8134","position":3,"is_corresponding":false},{"id":859469,"name":"Anil P. Bidkar","orcid":"0000-0003-1249-1081","position":4,"is_corresponding":false},{"id":768959,"name":"Chandrashekhar Dasari","orcid":"0000-0002-7526-2190","position":5,"is_corresponding":false},{"id":887919,"name":"Changhua Mu","orcid":"0000-0002-5007-0133","position":6,"is_corresponding":false},{"id":1245469,"name":"Ramya Ambur Sankaranarayanan","orcid":null,"position":7,"is_corresponding":false},{"id":841673,"name":"Juan A. Cámara","orcid":"0000-0001-7494-1127","position":8,"is_corresponding":false},{"id":1221619,"name":"Athira Raveendran","orcid":"0000-0002-4853-4330","position":9,"is_corresponding":false},{"id":227700,"name":"David Bulkley","orcid":"0000-0002-2535-904X","position":10,"is_corresponding":false},{"id":36081,"name":"Rahul Aggarwal","orcid":"0000-0001-7003-7982","position":11,"is_corresponding":false},{"id":336675,"name":"Nancy Greenland","orcid":"0000-0002-1783-1711","position":12,"is_corresponding":false},{"id":1243318,"name":"Adam Oskowitz","orcid":"0000-0002-7213-0555","position":13,"is_corresponding":false},{"id":488328,"name":"David M. Wilson","orcid":"0000-0002-1095-046X","position":14,"is_corresponding":false},{"id":325839,"name":"Youngho Seo","orcid":"0000-0001-5908-6636","position":15,"is_corresponding":false},{"id":894783,"name":"Daniel V. Santi","orcid":"0000-0002-3790-0673","position":16,"is_corresponding":false},{"id":401718,"name":"Henry F. VanBrocklin","orcid":"0000-0003-2849-0841","position":17,"is_corresponding":false},{"id":272317,"name":"Robert R. Flavell","orcid":"0000-0002-8694-1199","position":18,"is_corresponding":false},{"id":894778,"name":"Niranjan Meher","orcid":"0000-0003-3558-3712","position":0,"is_corresponding":true}],"reference_count":36,"raw_metadata":null,"created_at":"2026-07-19T02:00:16.989773Z","pmid":"38700450","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}